📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia. (2017)

First Author: Pleines I

Attributed to: Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci86154

PubMed Identifier: 28134622

Publication URI: http://europepmc.org/abstract/MED/28134622

Type: Journal Article/Review

Volume: 127

Parent Publication: The Journal of clinical investigation

Issue: 3

ISSN: 0021-9738